 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.5.4.2.1
- Phosphoglycerate mutase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
2-phospho-D-glycerate = 3-phospho-D-glycerate
|
 |
 |
 |
 |
 |
2-phospho-D-glycerate
|
=
|
3-phospho-D-glycerate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
cytoplasm
|
1 term
|
 |
|
Biological process
|
metabolic process
|
2 terms
|
 |
|
Biochemical function
|
catalytic activity
|
6 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Mol Biol
316:1071-1081
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Mechanistic implications for Escherichia coli cofactor-dependent phosphoglycerate mutase based on the high-resolution crystal structure of a vanadate complex.
|
|
C.S.Bond,
M.F.White,
W.N.Hunter.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The structure of Escherichia coli cofactor-dependent phosphoglycerate mutase
(dPGM), complexed with the potent inhibitor vanadate, has been determined to a
resolution of 1.30 A (R-factor 0.159; R-free 0.213). The inhibitor is present in
the active site, principally as divanadate, but with evidence of additional
vanadate moieties at either end, and representing a different binding mode to
that observed in the structural homologue prostatic acid phosphatase. The
analysis reveals the enzyme-ligand interactions involved in inhibition of the
mutase activity by vanadate and identifies a water molecule, observed in the
native E.coli dPGM structure which, once activated by vanadate, may
dephosphorylate the active protein. Rather than reflecting the active
conformation previously observed for E.coli dPGM, the inhibited protein's
conformation resembles that of the inactive dephosphorylated Saccharomyces
cerevisiae dPGM. The provision of a high-resolution structure of both active and
inactive forms of dPGM from a single organism, in conjunction with computational
modelling of substrate molecules in the active site provides insight into the
binding of substrates and the specific interactions necessary for three
different activities, mutase, synthase and phosphatase, within a single active
site. The sequence similarity of E.coli and human dPGMs allows us to correlate
structure with clinical pathology.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Inhibitor binding. (a) 1.75s 2F[o] - F[c]
s[A]-weighted[53] electron density (orange) covering
tetravanadate and the nearby residues Thr22 and Tyr91. Grey
balls-and-sticks represent oxygen atoms modelled with zero
occupancy. (b) Schematic of hydrogen bonding interactions
between tetravanadate and the protein. (c) Schematic of sulphate
binding positions in native dPGM structures. The Figure was
prepared using MOLSCRIPT, [54] O [43] and RASTER3D. [55]
|
 |
Figure 3.
Figure 3. Comparison of vanadate-binding of (a) dPGM and
(b) rat prostatic acid phosphatase. Vanadate shown as red and
grey ball-and-stick. Selected residues are shown as
ball-and-stick side-chains. Regions of structural homology are
depicted in dark blue, while regions that differ are shown in
(a) green and (b) cyan. Grey shading indicates the protein
surface cut away to reveal the active site shape.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2002,
316,
1071-1081)
copyright 2002.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.M.Foster,
P.J.Davis,
S.Raverdy,
M.H.Sibley,
E.A.Raleigh,
S.Kumar,
and
C.K.Carlow
(2010).
Evolution of bacterial phosphoglycerate mutases: non-homologous isofunctional enzymes undergoing gene losses, gains and lateral transfers.
|
| |
PLoS One, 5,
e13576.
|
 |
|
|
|
|
 |
K.van Eunen,
J.Bouwman,
P.Daran-Lapujade,
J.Postmus,
A.B.Canelas,
F.I.Mensonides,
R.Orij,
I.Tuzun,
J.van den Brink,
G.J.Smits,
W.M.van Gulik,
S.Brul,
J.J.Heijnen,
J.H.de Winde,
M.J.de Mattos,
C.Kettner,
J.Nielsen,
H.V.Westerhoff,
and
B.M.Bakker
(2010).
Measuring enzyme activities under standardized in vivo-like conditions for systems biology.
|
| |
FEBS J, 277,
749-760.
|
 |
|
|
|
|
 |
G.Kastenmuller,
M.E.Schenk,
J.Gasteiger,
and
H.W.Mewes
(2009).
Uncovering metabolic pathways relevant to phenotypic traits of microbial genomes.
|
| |
Genome Biol, 10,
R28.
|
 |
|
|
|
|
 |
J.Dai,
L.Finci,
C.Zhang,
S.Lahiri,
G.Zhang,
E.Peisach,
K.N.Allen,
and
D.Dunaway-Mariano
(2009).
Analysis of the structural determinants underlying discrimination between substrate and solvent in beta-phosphoglucomutase catalysis.
|
| |
Biochemistry, 48,
1984-1995.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.J.Myler,
R.Stacy,
L.Stewart,
B.L.Staker,
W.C.Van Voorhis,
G.Varani,
and
G.W.Buchko
(2009).
The Seattle Structural Genomics Center for Infectious Disease (SSGCID).
|
| |
Infect Disord Drug Targets, 9,
493-506.
|
 |
|
|
|
|
 |
L.Davies,
I.P.Anderson,
P.C.Turner,
A.D.Shirras,
H.H.Rees,
and
D.J.Rigden
(2007).
An unsuspected ecdysteroid/steroid phosphatase activity in the key T-cell regulator, Sts-1: surprising relationship to insect ecdysteroid phosphate phosphatase.
|
| |
Proteins, 67,
720-731.
|
 |
|
|
|
|
 |
L.Song,
Z.Xu,
and
X.Yu
(2007).
Molecular cloning and characterization of a phosphoglycerate mutase gene from Clonorchis sinensis.
|
| |
Parasitol Res, 101,
709-714.
|
 |
|
|
|
|
 |
U.Johnsen,
and
P.Schönheit
(2007).
Characterization of cofactor-dependent and cofactor-independent phosphoglycerate mutases from Archaea.
|
| |
Extremophiles, 11,
647-657.
|
 |
|
|
|
|
 |
K.A.Snyder,
H.J.Feldman,
M.Dumontier,
J.J.Salama,
and
C.W.Hogue
(2006).
Domain-based small molecule binding site annotation.
|
| |
BMC Bioinformatics, 7,
152.
|
 |
|
|
|
|
 |
T.K.Sigdel,
R.Cilliers,
P.R.Gursahaney,
P.Thompson,
J.A.Easton,
and
M.W.Crowder
(2006).
Probing the adaptive response of Escherichia coli to extracellular Zn(II).
|
| |
Biometals, 19,
461-471.
|
 |
|
|
|
|
 |
Y.Wang,
L.Liu,
Z.Wei,
Z.Cheng,
Y.Lin,
and
W.Gong
(2006).
Seeing the process of histidine phosphorylation in human bisphosphoglycerate mutase.
|
| |
J Biol Chem, 281,
39642-39648.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Müller,
M.R.Sawaya,
I.Pashkov,
S.Chan,
C.Nguyen,
Y.Wu,
L.J.Perry,
and
D.Eisenberg
(2005).
The 1.70 angstroms X-ray crystal structure of Mycobacterium tuberculosis phosphoglycerate mutase.
|
| |
Acta Crystallogr D Biol Crystallogr, 61,
309-315.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.G.Guerra,
D.Vertommen,
L.A.Fothergill-Gilmore,
F.R.Opperdoes,
and
P.A.Michels
(2004).
Characterization of the cofactor-independent phosphoglycerate mutase from Leishmania mexicana mexicana. Histidines that coordinate the two metal ions in the active site show different susceptibilities to irreversible chemical modification.
|
| |
Eur J Biochem, 271,
1798-1810.
|
 |
|
|
|
|
 |
Y.Wang,
Z.Cheng,
L.Liu,
Z.Wei,
M.Wan,
and
W.Gong
(2004).
Cloning, purification, crystallization and preliminary crystallographic analysis of human phosphoglycerate mutase.
|
| |
Acta Crystallogr D Biol Crystallogr, 60,
1893-1894.
|
 |
|
|
|
|
 |
Y.Wang,
Z.Wei,
Q.Bian,
Z.Cheng,
M.Wan,
L.Liu,
and
W.Gong
(2004).
Crystal structure of human bisphosphoglycerate mutase.
|
| |
J Biol Chem, 279,
39132-39138.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|